FMR LLC & Abigail Johnson Maintain 5.037% Stake in Vertex Pharma
Ticker: VRTX · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 875320
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals, passive-investing
TL;DR
**FMR LLC and Abigail Johnson still own over 5% of Vertex Pharma, showing continued institutional backing.**
AI Summary
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Vertex Pharmaceuticals Inc. As of December 31, 2023, they collectively beneficially own 12,981,286 shares of common stock, representing 5.037% of the company. This filing, an amendment to a previous SC 13G, indicates a slight adjustment in their reported holdings, which matters to investors as it shows a significant institutional investor maintaining a substantial position in Vertex, signaling continued confidence.
Why It Matters
This filing confirms a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, continue to hold a significant stake in Vertex Pharmaceuticals, which can be seen as a vote of confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces volatility and provides a level of confidence.
Analyst Insight
Investors should note that a major institutional holder, FMR LLC, is maintaining its position, suggesting continued confidence in Vertex Pharmaceuticals. This stability in institutional ownership can be a positive signal, but it doesn't necessarily indicate an immediate catalyst for price movement.
Key Numbers
- 12,981,286 — Shares Beneficially Owned (Represents the total common stock shares of Vertex Pharmaceuticals held by FMR LLC and Abigail P. Johnson.)
- 5.037% — Percent of Class (Indicates the proportion of Vertex Pharmaceuticals' common stock owned by FMR LLC and Abigail P. Johnson.)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person and principal owner of FMR LLC
- VERTEX PHARMACEUTICALS INC / MA (company) — the issuer of the securities
- 12,981,286 (dollar_amount) — total shares beneficially owned by FMR LLC and Abigail P. Johnson
- 5.037% (dollar_amount) — percentage of Vertex Pharmaceuticals common stock owned
Forward-Looking Statements
- FMR LLC will maintain a significant ownership stake in Vertex Pharmaceuticals for the foreseeable future. (FMR LLC) — high confidence, target: 2025-02-09
FAQ
Who are the reporting persons in this SC 13G/A filing?
The reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing for both entities.
What is the total number of shares of VERTEX PHARMACEUTICALS INC common stock beneficially owned by FMR LLC and Abigail P. Johnson?
Both FMR LLC and Abigail P. Johnson beneficially own 12,981,286 shares of VERTEX PHARMACEUTICALS INC common stock, as indicated in Item 7 on their respective cover pages and Item 4(a) for FMR LLC.
What percentage of VERTEX PHARMACEUTICALS INC's common stock do the reporting persons collectively own?
The reporting persons collectively own 5.037% of VERTEX PHARMACEUTICALS INC's common stock, as shown in Item 11 on their respective cover pages and Item 4(b) for FMR LLC.
What is the CUSIP number for VERTEX PHARMACEUTICALS INC common stock?
The CUSIP number for VERTEX PHARMACEUTICALS INC common stock is 92532F100, as stated in the filing under 'Cusip #92532F100' and Item 2(e).
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed pursuant to Rule 13d-1(b), as indicated by the checked box '[x] Rule 13d-1(b)' and Item 3, which specifies FMR LLC is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G).
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding VERTEX PHARMACEUTICALS INC / MA (VRTX).